{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:05:21Z","timestamp":1792724721073,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.tibtech.2012.12.006","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T08:32:32Z","timestamp":1358497952000},"page":"177-184","source":"Crossref","is-referenced-by-count":578,"title":["Combination approaches to combat multidrug-resistant bacteria"],"prefix":"10.1016","volume":"31","author":[{"given":"Roberta J.","family":"Worthington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2012.12.006_bib0005","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1126\/science.1164586","article-title":"Microbiology. Desperately seeking new antibiotics","volume":"321","author":"Payne","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0010","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","article-title":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999\u20132005","volume":"13","author":"Klein","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s15010-007-6269-7","article-title":"Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development","volume":"35","author":"Spellberg","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/cc9997","article-title":"New treatment options against gram-negative organisms","volume":"15","author":"Bassetti","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1155\/2005\/892058","article-title":"Where are all the new antibiotics? The new antibiotic paradox","volume":"16","author":"Conly","year":"2005","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0035","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/35021219","article-title":"Molecular mechanisms that confer antibacterial drug resistance","volume":"406","author":"Walsh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nm1010-1054a","article-title":"Sequencing of superbugs seen as key to combating their spread","volume":"16","author":"Dolgin","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt0206-163","article-title":"Designer combination therapy for cancer","volume":"24","author":"Lane","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0050","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35073673","article-title":"HIV chemotherapy","volume":"410","author":"Richman","year":"2001","journal-title":"Nature"},{"issue":"6 Suppl.","key":"10.1016\/j.tibtech.2012.12.006_bib0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0060","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5588\/ijtld.12.0083","article-title":"The chemotherapy of tuberculosis: past, present and future","volume":"16","author":"Mitchison","year":"2012","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0270","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","article-title":"Combination therapies for combating antimicrobial resistance","volume":"14","author":"Fischbach","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/cb100269f","article-title":"Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus","volume":"6","author":"Campbell","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0080","article-title":"Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to beta-lactams","author":"Farha","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"Suppl. A","key":"10.1016\/j.tibtech.2012.12.006_bib0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/39.suppl_1.47","article-title":"Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics","volume":"39","author":"Sieradzki","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. 2","key":"10.1016\/j.tibtech.2012.12.006_bib0090","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.ijantimicag.2007.07.037","article-title":"The clinical development and launch of amoxicillin\/clavulanate for the treatment of a range of community-acquired infections","volume":"30","author":"Ball","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0100","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology","volume":"12","author":"Poirel","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jac\/dkq520","article-title":"Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?","volume":"66","author":"Nordmann","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0110","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1128\/AAC.01549-08","article-title":"Efficacy of piperacillin combined with the penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection","volume":"53","author":"Petersen","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/AAC.00085-08","article-title":"In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor","volume":"53","author":"Paukner","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0120","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-beta-lactam beta-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0125","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.01370-10","article-title":"In vitro and in vivo properties of BAL30376, a beta-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative bacilli that express multiple beta-lactamases","volume":"55","author":"Page","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0135","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbapap.2008.12.011","article-title":"Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria","volume":"1794","author":"Pages","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.bcp.2005.12.008","article-title":"Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use","volume":"71","author":"Lomovskaya","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AAC.00735-10","article-title":"Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor","volume":"55","author":"Kalle","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0150","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/jm201446h","article-title":"Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors","volume":"55","author":"Sabatini","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mib.2010.01.008","article-title":"Two-component signal transduction as potential drug targets in pathogenic bacteria","volume":"13","author":"Gotoh","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0160","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/AAC.00356-06","article-title":"Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus","volume":"50","author":"Gardete","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0165","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/AAC.01704-10","article-title":"Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion","volume":"55","author":"Jo","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0170","doi-asserted-by":"crossref","first-page":"14570","DOI":"10.1073\/pnas.0903619106","article-title":"Targeting a bacterial stress response to enhance antibiotic action","volume":"106","author":"Lee","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0175","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1128\/AAC.00284-09","article-title":"Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system","volume":"53","author":"Adams","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0180","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/AAC.00079-11","article-title":"Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system","volume":"55","author":"Beceiro","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0185","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/AAC.00285-06","article-title":"High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35\/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE","volume":"50","author":"Kaczmarek","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0190","doi-asserted-by":"crossref","first-page":"e33777","DOI":"10.1371\/journal.pone.0033777","article-title":"Role of the two component signal transduction system CpxAR in conferring cefepime and chloramphenicol resistance in Klebsiella pneumoniae NTUH-K2044","volume":"7","author":"Srinivasan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0195","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0968-0896(01)00355-8","article-title":"Histidine kinases as targets for new antimicrobial agents","volume":"10","author":"Matsushita","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0275","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1073\/pnas.95.9.5317","article-title":"Antibacterial agents that inhibit two-component signal transduction systems","volume":"95","author":"Barrett","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0200","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1128\/AAC.01418-09","article-title":"Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents","volume":"54","author":"Rogers","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0280","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/cmdc.201100316","article-title":"Evaluation of 4,5-disubstituted-2-aminoimidazole-triazole conjugates for antibiofilm\/antibiotic resensitization activity against MRSA and Acinetobacter baumannii","volume":"6","author":"Su","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0315","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/cmdc.201200350","article-title":"Structural studies on 4,5-disubstituted-2-aminoimidazole-based biofilm modulators that suppress bacterial resistance to \u03b2-lactams","volume":"7","author":"Su","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0290","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1039\/C2OB26469B","article-title":"N-Substituted 2-aminoimidazole inhibitors of MRSA biofilm formation accessed through direct 1,3-bis(tert-butoxycarbonyl)guanidine cyclization","volume":"11","author":"Yeagley","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0295","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1002\/anie.201206911","article-title":"Potent small-molecule suppression of oxacillin resistance in methicillin-resistant Staphylococcus aureus","volume":"51","author":"Harris","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/ml200290p","article-title":"Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae","volume":"3","author":"Worthington","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0215","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10096-009-0739-z","article-title":"The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target","volume":"28","author":"Mazumdar","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0220","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0225","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dkm071","article-title":"Reversal of resistance in microorganisms by help of non-antibiotics","volume":"59","author":"Kristiansen","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0300","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijantimicag.2012.01.012","article-title":"Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections","volume":"39","author":"Amaral","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0230","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jac\/dkn417","article-title":"Reversal of methicillin resistance in Staphylococcus aureus by thioridazine","volume":"62","author":"Klitgaard","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0305","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1574-6968.2011.02255.x","article-title":"Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus","volume":"318","author":"Bonde","year":"2011","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0235","article-title":"Thioridazine potentiates the effect of a beta-lactam antibiotic against Staphylococcus aureus independently of mecA expression","author":"Poulsen","year":"2012","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0240","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jac\/38.6.1049","article-title":"Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis","volume":"38","author":"Amaral","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tibtech.2012.12.006_bib0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0924-8579(00)00199-0","article-title":"Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis","volume":"16","author":"Bettencourt","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0245","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijantimicag.2009.12.019","article-title":"Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!","volume":"35","author":"Amaral","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0250","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","article-title":"Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines","volume":"17","author":"Miguel Viveiros","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0255","first-page":"5","article-title":"The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis","author":"van Soolingen","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijantimicag.2007.02.019","article-title":"Promethazine renders Escherichia coli susceptible to penicillin G: real-time measurement of bacterial susceptibility by fluoro-luminometry","volume":"30","author":"Lehtinen","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.tibtech.2012.12.006_bib0265","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/cb300269g","article-title":"A forward chemical screen identifies antibiotic adjuvants in Escherichia coli","volume":"7","author":"Taylor","year":"2012","journal-title":"ACS Chem. Biol."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779912002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779912002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T09:32:23Z","timestamp":1562578343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779912002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0167779912002259"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2012.12.006","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}